1Salim A, Rengifo-Parclo M, Vincent S, et al. Melasma//Williams H, Bigby M, Diepgen T, et al. Evidence-based dermatology. London : BMJ Books ,2003:553-567.
2Piamphongsant T. Treatment of melasma: a review with personal experience. Int J Dermatol, 1998,37:897-903.
3Palumbo A, d' Ischia M, Misuraca G, et al. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta, 1991,1073:85-90.
4Haddad AL,Matos LF,Brunstein F,et al. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol,2003,42 : 153-156.
5Romero C, Aberdam E, Larnier C, et al. Retinoic acid as modulator of UVB-induced melanocyte differentiation. Involvement of the melanogenic enzymes expression. J Cell Sci, 1994, 107 : 1095-1103.
6Kimbrough-Green CK, Griffiths CE, Finkel LJ, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehiclecontrolled clinical trial. Arch Dermatol, 1994,130:727-733.
7Leenutaphong V, Nettakul A, Rattanasuwon P. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial. J Med Assoc Thai, 1999,82:868-875.
8Shroot B. Pharmacodynamics and pharmacokinetics of topical adapalene. J Am Acad Dermatol, 1998,39( 2 Pt 3 ) :S17-24.
9Dogra S, Kanwar AJ, Parasad D. Adapalene in the treatment of melasma: a preliminary report. J Dermatol,2002 ,29 :539-540.
10Rigoni C, Toffolo P, Serri R, et al. Use of a cream based on 20% azelaic acid in the treatment of melasma. G Ital Dermatol Venereol,1989,124:Ⅰ-Ⅳ.
